# Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants

> **NCT07680686** · PHASE1 · RECRUITING · sponsor: **AbbVie** · enrollment: 52 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Ubrogepant
- **DRUG:** Ubrogepant

## Key facts

- **NCT ID:** NCT07680686
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680686, "Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*